摘要
AS a distinguished expert on China’s Thousand Talents Program,Yu Dechao is a heavyweight in the country’s biological pharmacy.As a major founder of Oncorine,the world’s first patented anti-tumor virus therapy drug,he also invented Conbercept,China’s first monoclonal antibody drug whose global intellectual property rights it owns.
AS a distinguished expert on China’s Thousand Talents Program,Yu Dechao is a heavyweight in the country’s biological pharmacy.As a major founder of Oncorine,the world’s first patented anti-tumor virus therapy drug,he also invented Conbercept,China’s first monoclonal antibody drug whose global intellectual property rights it owns.It is applied as an ophthalmic injection which restores light sensitivity to eyes blinded by age-
